Tergus Pharma has acquired EnDev Laboratories, a Dermatology-centric CRO based in Kannapolis, NC. The acquisition will add extensive early-phase drug development capabilities from lead compound selection to skin biology.   Founded in 2016, EnDev will provide a synergy to consolidate Tergus’ growth in dermatological R&D, and significant skin biology research capability that includes skin irritation, skin sensitization, and drug activity testing using healthy or genetically-modified In...